0 CHECKOUT

OTC Pharmaceuticals in United Arab Emirates

  • ID: 2113055
  • September 2014
  • Region: United Arab Emirates
  • 39 pages
  • MarketLine

Introduction

OTC Pharmaceuticals in United Arab Emirates industry profile provides top-line qualitative and quantitative summary information including: market size (value 2009-13, and forecast to 2018). The profile also contains descriptions of the leading players including key financial metrics and analysis of competitive pressures within the market. Essential resource for top-line data and analysis covering the United Arab Emirates otc pharmaceuticals market. Includes market size data, textual and graphical analysis of market growth trends, leading companies and macroeconomic information.

Highlights

- The OTC pharmaceuticals market consists of the retail sale of traditional medicines, cough and cold preparations (tablets, mixtures, lozenges, topical remedies, inhalers), vitamins and minerals (multi-vitamins, single minerals, single vitamins, tonics, cod liver oil), indigestion preparations (tablets, powders, mixtures), analgesics (Paracetamol, Ibuprofen, Aspirin and other analgesics), and medicated skin products (anti-bacterials, acne treatments, anti-fungal, disinfectants and other), topical OTC medicines (anesthetic products, anti-itch products, antibiotic creams/gels), READ MORE >

Note: Product cover images may vary from those shown

Executive Summary

Market value

Market value forecast

Category segmentation

Geography segmentation

Market share

Market rivalry

Market Overview

Market definition

Market analysis

Market Data

Market value

Market Segmentation

Category segmentation

Geography segmentation

Market share

Market distribution

Market Outlook

Market value forecast

Five Forces Analysis

Summary

Buyer power

Supplier power

New entrants

Threat of substitutes

Degree of rivalry

Leading Companies

Bayer AG

GlaxoSmithKline Plc

Johnson & Johnson

Novartis AG

Macroeconomic Indicators

Country Data

Appendix

Methodology

Industry associations

Related research

LIST OF TABLES

Table 1: United Arab Emirates OTC pharmaceuticals market value: $ million, 2009–13

Table 2: United Arab Emirates OTC pharmaceuticals market category segmentation: $ million, 2013

Table 3: United Arab Emirates OTC pharmaceuticals market geography segmentation: $ million, 2013

Table 4: United Arab Emirates OTC pharmaceuticals market share: % share, by value, 2013

Table 5: United Arab Emirates OTC pharmaceuticals market distribution: % share, by value, 2013

Table 6: United Arab Emirates OTC pharmaceuticals market value forecast: $ million, 2013–18

Table 7: Bayer AG: key facts

Table 8: Bayer AG: key financials ($)

Table 9: Bayer AG: key financials (€)

Table 10: Bayer AG: key financial ratios

Table 11: GlaxoSmithKline Plc: key facts

Table 12: GlaxoSmithKline Plc: key financials ($)

Table 13: GlaxoSmithKline Plc: key financials (£)

Table 14: GlaxoSmithKline Plc: key financial ratios

Table 15: Johnson & Johnson: key facts

Table 16: Johnson & Johnson: key financials ($)

Table 17: Johnson & Johnson: key financial ratios

Table 18: Novartis AG: key facts

Table 19: Novartis AG: key financials ($)

Table 20: Novartis AG: key financial ratios

Table 21: United Arab Emirates size of population (million), 2009–13

Table 22: United Arab Emirates gdp (constant 2005 prices, $ billion), 2009–13

Table 23: United Arab Emirates gdp (current prices, $ billion), 2009–13

Table 24: United Arab Emirates inflation, 2009–13

Table 25: United Arab Emirates consumer price index (absolute), 2009–13

Table 26: United Arab Emirates exchange rate, 2009–13

LIST OF FIGURES

Figure 1: United Arab Emirates OTC pharmaceuticals market value: $ million, 2009–13

Figure 2: United Arab Emirates OTC pharmaceuticals market category segmentation: % share, by value, 2013

Figure 3: United Arab Emirates OTC pharmaceuticals market geography segmentation: % share, by value, 2013

Figure 4: United Arab Emirates OTC pharmaceuticals market share: % share, by value, 2013

Figure 5: United Arab Emirates OTC pharmaceuticals market distribution: % share, by value, 2013

Figure 6: United Arab Emirates OTC pharmaceuticals market value forecast: $ million, 2013–18

Figure 7: Forces driving competition in the OTC pharmaceuticals market in United Arab Emirates, 2013

Figure 8: Drivers of buyer power in the OTC pharmaceuticals market in United Arab Emirates, 2013

Figure 9: Drivers of supplier power in the OTC pharmaceuticals market in United Arab Emirates, 2013

Figure 10: Factors influencing the likelihood of new entrants in the OTC pharmaceuticals market in United Arab Emirates, 2013

Figure 11: Factors influencing the threat of substitutes in the OTC pharmaceuticals market in United Arab Emirates, 2013

Figure 12: Drivers of degree of rivalry in the OTC pharmaceuticals market in United Arab Emirates, 2013

Figure 13: Bayer AG: revenues & profitability

Figure 14: Bayer AG: assets & liabilities

Figure 15: GlaxoSmithKline Plc: revenues & profitability

Figure 16: GlaxoSmithKline Plc: assets & liabilities

Figure 17: Johnson & Johnson: revenues & profitability

Figure 18: Johnson & Johnson: assets & liabilities

Figure 19: Novartis AG: revenues & profitability

Figure 20: Novartis AG: assets & liabilities

Note: Product cover images may vary from those shown

GlaxoSmithKline Plc, Johnson & Johnson, Novartis AG and WellSpring Pharmaceuticals

Note: Product cover images may vary from those shown
Note: Product cover images may vary from those shown

PLEASE SELECT A FORMAT

  • Quick Help: The report will be emailed to you. The report is sent in PDF format. This is a single user license, allowing one specific user access to the product.

  • Quick Help: The report will be emailed to you. The report is sent in PDF format. This is an enterprise license, allowing all employees within your organisation access to the product.

HAVE A QUESTION?

If you have a more general question about our products please try our

FAQ SECTION

RELATED PRODUCTS

Our Clients

  • Johnson & Johnson Services, Inc.
  • Procter & Gamble Co.
  • Sanofi S.A.
  • GlaxoSmithKline PLC
  • Novartis AG
  • Pfizer, Inc.
  • Boehringer Ingelheim GmbH